Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Follow us on Google+Follow us on TwitterFind us on LinkedInFind Us on FacebookSubscribe to our RSS FeedsSubscribe to our YouTube ChannelFind us on RebelMouse

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for January 04, 2014 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



Johnson & Johnson agrees to $2.47 billion settlement for all-metal implants

DePuy, a leading manufacturer of hip implants, recently agreed to a settlement because of its defective all-metal implants.
 
x-small text small text medium text large text

    January 04, 2014 /24-7PressRelease/ -- Ten years ago, all-metal hip replacements were expected to revolutionize the industry. The implants, which used metal for both the ball and socket of the hip, were expected to replace the metal and plastic hip joints that had been used previously. Metal and plastic hip joints would often wear out after about 15 years and would need to be replaced. All-metal hip replacements promised more durability.

As a result, all metal implants were initially a popular choice with orthopedic surgeons. About one-third of the 93,000 sold by DePuy Orthopedics, a Johnson & Johnson company went to patients in the United States. However, DePuy, a leading manufacturer of all-metal implants has been named in numerous defective product lawsuits recently due to widespread reports of premature failure and health injuries.

Settlement after a history of failure

Although all metal implants promised more durability than previous models, it was discovered that the devices often failed much earlier, due to the friction generated as the metal components rubbed against one another during use. According to company documents, at least 37 percent of the devices failed after only 4.6 years--eight times the failure rate of previous devices. In addition to causing the replacement to wear out prematurely, it was found that the friction would cause metal particles to be released into the body, causing a host of medical problems.

As a result of the thousands of lawsuits filed because of the device's problems, DePuy recalled the Articular Surface Replacement (ASR) model in 2010. Most recently, DePuy announced that it would pay at least $2.47 billion to settle the estimated 8,000 lawsuits related to the ASR device. If approved by the court, the DuPuy settlement would be among one of the largest settlements involving a defective medical device. Although the settlement would resolve the majority of the lawsuits involving the ASR device, it would not affect the estimated 4,000 remaining lawsuits involving another all metal device, the Pinnacle, which has been discontinued.

Consult an attorney

The DePuy settlement is a victory for those who have suffered debilitating medical issues as a result of the device. Besides having to undergo surgery to replace the defective device, many of such persons experienced pain and damage to the heart, thyroid, nerves and surrounding tissues, due to the elevated chromium levels in the blood caused by the shredding of metal.

If you have received an all-metal hip replacement, you may be entitled to compensation. An experienced personal injury attorney can advise you of your rights and work to recover all compensation due to you by law.

Article provided by Charles G. Monnett III & Associates
Visit us at www.carolinalaw.com



---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Read more Press Releases from FL Web Advantage:


Contact Information:
FL Web Advantage

E-Mail: Email us Here
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.